Welcome to Cangrelor Pre Activity assessment.
Thank you and congratulations for attending this educational activity. Remember, continuous professional development is key to success and professional excellence.
Thank you
Cangrelor Pre-Assessment
Quiz Summary
0 of 4 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 4 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 4
1. Question
Which statement is correct regarding cangrelor pharmacologic category:
CorrectIncorrect -
Question 2 of 4
2. Question
In transitioning patients to oral P2Y12 antagonist therapy after PCI we can administer 600 mg of clopidogrel immediately after discontinuing cangrelor infusion
CorrectIncorrect -
Question 3 of 4
3. Question
Cangrelor may diminish the antiplatelet effect of clopidogrel:
CorrectIncorrect -
Question 4 of 4
4. Question
Cangrelor is contraindicated in pregnancy (category x)
CorrectIncorrect